The cysG gene of Salmonella typhimurium is involved in synthesis of both cobalamin (B 12 ) and siroheme (a cofactor required for SO 3 2؊ and NO 2 2؊ reductases). The failure to reduce SO 3 2؊ leads to cysteine auxotrophy, for which the enzyme is named. Although Escherichia coli does not synthesize B 12 de novo, it possesses a very similar CysG enzyme which has been shown to catalyze two methylations (uroporphyrinogen III to precorrin-2), ring oxidation (precorrin-2 to factor II), and iron insertion (factor II to siroheme). In S. typhimurium, precorrin-2 is a precursor of both siroheme and B 12 . All previously known Salmonella cysG mutants are defective in the synthesis of both siroheme and cobalamin. We describe two new classes of cysG mutants that cannot synthesize B 12 but still make siroheme. For class I mutants, exogenous cobalt corrects the B 12 defect but inhibits ability to make siroheme; B 12 synthesis is inhibited by added iron. Class II mutants are unaffected by exogenous cobalt, but their B 12 defect is corrected by derepression of the B 12 biosynthetic genes (cob). We propose that all mutants are defective in insertion of cobalt into factor II and that the Salmonella CysG enzyme normally catalyzes this insertion-the first reaction dedicated to cobalamin synthesis. Although E. coli does not make B 12 , its CysG enzyme has been shown in vitro to insert cobalt into factor II and may have evolved to support B 12 synthesis in some ancestor common to Salmonella species and E. coli.